If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

AVXL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,138,640.00

Anavex Life Sciences Insider Trading History Chart

Anavex Life Sciences Share Price & Price History

^$6.93

▼ -0.04 (-0.57%)

As of 09/22/2023 11:21 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Anavex Life Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/28/2023	Christopher U Missling	CEO	Sell	268,000	$7.98	$2,138,640.00	1,018,210
5/25/2022	Athanasios Skarpelos	Director	Sell	50,000	$9.06	$453,000.00	1,306,458
6/29/2021	Sandra Boenisch	Treasurer	Sell	166,696	$26.53	$4,422,444.88	47,963
5/21/2021	Elliot Favus	Director	Sell	145,000	$11.70	$1,696,500.00	37,500
5/17/2021	Peter D.O. Donhauser	Director	Buy	1,000	$10.93	$10,930.00	2,165
2/24/2021	Elliot Favus	Director	Sell	145,500	$12.66	$1,842,030.00	45,000
2/19/2021	Peter D.O. Donhauser	Director	Buy	1,165	$12.67	$14,760.55	1,000

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Anavex Life Sciences (NASDAQ:AVXL)

30.79% of Anavex Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Anavex Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/12/2023	Prosperity Financial Group Inc.	23,897	$0.19M	0.2%	-50.2%	0.029%
8/21/2023	Osaic Holdings Inc.	13,142	$0.11M	0.0%	-11.2%	0.016%
8/15/2023	Wells Fargo & Company MN	156,690	$1.27M	0.0%	-1.8%	0.191%
8/15/2023	Dana Investment Advisors Inc.	11,855	$96K	0.0%	+10.9%	0.014%
8/15/2023	XTX Topco Ltd	21,423	$0.17M	0.0%	+62.2%	0.026%
8/15/2023	Goldman Sachs Group Inc.	320,200	$2.60M	0.0%	-23.6%	0.391%
8/15/2023	Royal Bank of Canada	20,565	$0.17M	0.0%	+10.4%	0.025%
8/15/2023	Bridgefront Capital LLC	23,507	$0.19M	0.1%	+15.6%	0.029%
8/14/2023	Tower Research Capital LLC TRC	5,449	$44K	0.0%	+32.9%	0.007%
8/14/2023	Schonfeld Strategic Advisors LLC	15,683	$0.13M	0.0%	N/A	0.019%
8/14/2023	Marshall Wace LLP	11,299	$92K	0.0%	-76.3%	0.014%
8/14/2023	State of Wisconsin Investment Board	68,348	$0.56M	0.0%	-17.3%	0.083%
8/14/2023	State Street Corp	4,408,937	$35.85M	0.0%	-22.3%	5.380%
8/11/2023	Natixis	8,000	$65K	0.0%	N/A	0.010%
8/11/2023	Credit Suisse AG	114,474	$0.93M	0.0%	+28.4%	0.140%
8/11/2023	BlackRock Inc.	5,938,968	$48.28M	0.0%	+3.5%	7.247%
8/11/2023	State Board of Administration of Florida Retirement System	19,935	$0.16M	0.0%	+9.0%	0.024%
8/11/2023	The Manufacturers Life Insurance Company	27,048	$0.22M	0.0%	+5.9%	0.033%
8/11/2023	Franklin Resources Inc.	34,701	$0.28M	0.0%	N/A	0.042%
8/11/2023	Geode Capital Management LLC	1,542,300	$12.54M	0.0%	+6.2%	1.882%
8/11/2023	E Fund Management Co. Ltd.	18,853	$0.15M	0.0%	-28.6%	0.023%
8/11/2023	JPMorgan Chase & Co.	59,286	$0.48M	0.0%	+2.7%	0.072%
8/11/2023	PNC Financial Services Group Inc.	18,714	$0.15M	0.0%	+7.2%	0.023%
8/11/2023	Northern Trust Corp	735,988	$5.98M	0.0%	+1.2%	0.898%
8/11/2023	ExodusPoint Capital Management LP	76,029	$0.62M	0.0%	-21.3%	0.094%
8/10/2023	Osaic Holdings Inc.	13,142	$0.11M	0.0%	-11.2%	0.016%
8/10/2023	Profund Advisors LLC	63,654	$0.52M	0.0%	-25.9%	0.079%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	45,992	$0.37M	0.0%	-11.1%	0.057%
8/10/2023	Private Advisor Group LLC	31,680	$0.26M	0.0%	-19.1%	0.039%
8/10/2023	Nwam LLC	634,600	$5.16M	0.4%	+15.8%	0.785%
8/10/2023	Cetera Advisor Networks LLC	83,678	$0.68M	0.0%	+6.1%	0.104%
8/10/2023	Charles Schwab Investment Management Inc.	581,262	$4.73M	0.0%	+3.8%	0.719%
8/10/2023	Citigroup Inc.	124,060	$1.01M	0.0%	-67.2%	0.153%
8/9/2023	BNP Paribas Arbitrage SNC	71,296	$0.58M	0.0%	-58.3%	0.088%
8/9/2023	Lido Advisors LLC	12,100	$98K	0.0%	N/A	0.015%
8/9/2023	Swiss National Bank	173,300	$1.41M	0.0%	+3.0%	0.214%
8/8/2023	Rhumbline Advisers	102,138	$0.83M	0.0%	+14.1%	0.126%
8/7/2023	Principal Financial Group Inc.	20,955	$0.17M	0.0%	+8.8%	0.026%
8/4/2023	Saturna Capital CORP	12,540	$0.10M	0.0%	-30.1%	0.016%
8/4/2023	Carnegie Capital Asset Management LLC	68,060	$0.55M	0.0%	+55.8%	0.084%
8/4/2023	Liberty One Investment Management LLC	15,826	$0.13M	0.0%	+22.4%	0.020%
8/3/2023	Barclays PLC	192,151	$1.56M	0.0%	+1.3%	0.234%
8/3/2023	Bank of New York Mellon Corp	256,709	$2.09M	0.0%	+0.9%	0.318%
7/31/2023	LPL Financial LLC	60,905	$0.50M	0.0%	+23.9%	0.075%
7/27/2023	Virtu Financial LLC	11,507	$94K	0.0%	-83.2%	0.014%
7/26/2023	Janney Montgomery Scott LLC	25,681	$0.21M	0.0%	N/A	0.032%
7/25/2023	Raymond James Financial Services Advisors Inc.	33,320	$0.27M	0.0%	+4.1%	0.041%
7/20/2023	Baker Tilly Wealth Management LLC	25,224	$0.21M	0.0%	+152.2%	0.031%
7/19/2023	Teacher Retirement System of Texas	21,592	$0.18M	0.0%	-10.1%	0.027%
7/18/2023	Allworth Financial LP	11,018	$90K	0.0%	N/A	0.014%
7/18/2023	Fiduciary Alliance LLC	9,275	$75K	0.0%	N/A	0.011%
7/13/2023	Miracle Mile Advisors LLC	15,492	$0.13M	0.0%	N/A	0.019%
5/26/2023	ProShare Advisors LLC	13,549	$0.12M	0.0%	-11.7%	0.017%
5/18/2023	JPMorgan Chase & Co.	57,722	$0.50M	0.0%	+31.3%	0.071%
5/18/2023	New York State Common Retirement Fund	39,296	$0.34M	0.0%	-18.8%	0.049%
5/16/2023	State Street Corp	5,677,376	$48.66M	0.0%	-2.3%	7.023%
5/16/2023	Geode Capital Management LLC	1,452,878	$12.45M	0.0%	+3.4%	1.797%
5/16/2023	AQR Capital Management LLC	12,441	$0.11M	0.0%	-51.0%	0.015%
5/16/2023	Balyasny Asset Management L.P.	30,275	$0.26M	0.0%	-48.7%	0.037%
5/15/2023	Two Sigma Advisers LP	180,600	$1.55M	0.0%	+65.5%	0.223%
5/15/2023	Two Sigma Investments LP	260,030	$2.23M	0.0%	+79.6%	0.322%
5/15/2023	Deutsche Bank AG	50,326	$0.43M	0.0%	+21.9%	0.062%
5/15/2023	XTX Topco Ltd	13,211	$0.11M	0.0%	-65.5%	0.017%
5/12/2023	Nwam LLC	548,237	$4.70M	0.5%	N/A	0.689%
5/12/2023	BlackRock Inc.	5,737,650	$49.17M	0.0%	+2.9%	7.207%
5/12/2023	BNP Paribas Arbitrage SNC	170,896	$1.47M	0.0%	+31.4%	0.215%
5/12/2023	Independent Advisor Alliance	28,530	$0.25M	0.0%	N/A	0.036%
5/12/2023	UBS Group AG	182,350	$1.56M	0.0%	-42.1%	0.229%
5/12/2023	ProShare Advisors LLC	13,549	$0.12M	0.0%	-11.7%	0.017%
5/12/2023	Charles Schwab Investment Management Inc.	560,043	$4.80M	0.0%	-1.0%	0.704%
5/12/2023	Profund Advisors LLC	85,912	$0.74M	0.0%	N/A	0.108%
5/11/2023	ExodusPoint Capital Management LP	96,585	$0.83M	0.0%	-29.6%	0.121%
5/11/2023	Rhumbline Advisers	89,519	$0.77M	0.0%	+3.7%	0.112%
5/11/2023	Commonwealth Equity Services LLC	87,770	$0.75M	0.0%	-3.6%	0.110%
5/11/2023	Citigroup Inc.	377,924	$3.24M	0.0%	+78.8%	0.475%
5/11/2023	E Fund Management Co. Ltd.	26,414	$0.23M	0.0%	+8.4%	0.033%
5/10/2023	Private Advisor Group LLC	39,180	$0.34M	0.0%	N/A	0.049%
5/10/2023	Credit Suisse AG	89,163	$0.76M	0.0%	+4.9%	0.112%
5/10/2023	Swiss National Bank	168,300	$1.44M	0.0%	-10.6%	0.211%
5/9/2023	Principal Financial Group Inc.	19,265	$0.17M	0.0%	-7.0%	0.024%
5/9/2023	Tower Research Capital LLC TRC	4,101	$35K	0.0%	-23.1%	0.005%
5/9/2023	Bank of New York Mellon Corp	254,523	$2.18M	0.0%	+2.4%	0.320%
5/9/2023	California State Teachers Retirement System	94,198	$0.81M	0.0%	-1.2%	0.118%
5/4/2023	Barclays PLC	189,613	$1.63M	0.0%	+1,796.1%	0.238%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	51,724	$0.44M	0.0%	+51.5%	0.065%
5/3/2023	Jump Financial LLC	23,000	$0.20M	0.0%	-63.7%	0.029%
5/2/2023	Amalgamated Bank	9,531	$82K	0.0%	-13.2%	0.012%
5/1/2023	Virtu Financial LLC	68,365	$0.59M	0.1%	+130.9%	0.086%
4/28/2023	SG Americas Securities LLC	31,382	$0.27M	0.0%	+83.8%	0.039%
4/25/2023	Geneos Wealth Management Inc.	42,100	$0.36M	0.0%	+5.0%	0.053%
4/21/2023	BNC Wealth Management LLC	13,050	$0.11M	0.1%	N/A	0.016%
4/20/2023	Hennion & Walsh Asset Management Inc.	70,558	$0.61M	0.0%	-2.3%	0.089%
4/20/2023	Carnegie Capital Asset Management LLC	43,675	$0.37M	0.0%	+132.9%	0.055%
4/14/2023	Raymond James & Associates	13,195	$0.11M	0.0%	N/A	0.017%
2/15/2023	Pier Capital LLC	280,854	$2.60M	0.4%	-27.0%	0.360%
2/15/2023	Virtu Financial LLC	29,614	$0.27M	0.0%	N/A	0.038%
2/15/2023	State of Wisconsin Investment Board	73,322	$0.68M	0.0%	-6.0%	0.094%
2/15/2023	Legal & General Group Plc	36,150	$0.34M	0.0%	+3.2%	0.046%
2/15/2023	Millennium Management LLC	833,524	$7.72M	0.0%	+309.9%	1.068%
2/15/2023	Morgan Stanley	383,483	$3.55M	0.0%	+75.8%	0.491%

Data available starting January 2016

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia; and preclinical clinical trials for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.

Today's Range

Now: $6.93

$6.84

$7.00

50 Day Range

MA: $8.05

$6.97

$9.37

52 Week Range

Now: $6.93

$6.81

$15.24

Volume

135,165 shs

Average Volume

1,002,833 shs

Market Capitalization

$567.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.68

Who are the company insiders with the largest holdings of Anavex Life Sciences?: Anavex Life Sciences' top insider shareholders include:
Athanasios Skarpelos (Director)
Christopher U Missling (CEO)
Learn More about top insider investors at Anavex Life Sciences.
Who are the major institutional investors of Anavex Life Sciences?: Anavex Life Sciences' top institutional shareholders include:
BlackRock Inc. — 7.25%
State Street Corp — 5.38%
Geode Capital Management LLC — 1.88%
Northern Trust Corp — 0.90%
Nwam LLC — 0.79%
Charles Schwab Investment Management Inc. — 0.72%
Learn More about top institutional investors of Anavex Life Sciences stock.
Which major investors are selling Anavex Life Sciences stock?: In the previous quarter, AVXL stock was sold by these institutional investors:
State Street Corp
Citigroup Inc.
BNP Paribas Arbitrage SNC
Goldman Sachs Group Inc.
Virtu Financial LLC
Marshall Wace LLP
Prosperity Financial Group Inc.
Profund Advisors LLC
Which major investors are buying Anavex Life Sciences stock?: In the last quarter, AVXL stock was acquired by institutional investors including:
BlackRock Inc.
Geode Capital Management LLC
Nwam LLC
Citadel Advisors LLC
Franklin Resources Inc.
Janney Montgomery Scott LLC
Credit Suisse AG
Carnegie Capital Asset Management LLC

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

AVXL Insider Trading

Anavex Life Sciences Insider Trading History Chart

Anavex Life Sciences Share Price & Price History

Anavex Life Sciences Insider Trading History

SEC Filings (Institutional Ownership Changes) for Anavex Life Sciences (NASDAQ:AVXL)

Institutional Buying and Selling by Quarter

Anavex Life Sciences Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Anavex Life Sciences?

Who are the major institutional investors of Anavex Life Sciences?

Which major investors are selling Anavex Life Sciences stock?

Which major investors are buying Anavex Life Sciences stock?